Trimethoprim-sulfamethoxazole for cholangitis following hepatic portoenterostomy for biliary atresia.
D001424:Bacterial Infections / Q000188:drug therapy*; D001652:Bile Ducts / Q000002:abnormalities*; D002761:Cholangitis / Q000188:drug therapy* / Q000517:prevention & control; D004338:Drug Combinations; D004927:Escherichia coli Infections / Q000188:drug therapy; D005260:Female; D006801:Humans; D007223:Infant; D007422:Intestines / Q000601:surgery; D008099:Liver / Q000601:surgery; D008297:Male; D008722:Methods; D011183:Postoperative Complications / Q000188:drug therapy; D011552:Pseudomonas Infections / Q000188:drug therapy; D013420:Sulfamethoxazole / Q000009:adverse effects / Q000627:therapeutic use*; D014295:Trimethoprim / Q000009:adverse effects / Q000627:therapeutic use*
D004338:Drug Combinations; D014295:Trimethoprim; D013420:Sulfamethoxazole